Value of dynamic contrast-enhanced MRI and correlation with tumor angiogenesis in bladder cancer

American Journal of Roentgenology

Volumn 192, Issue 4, 2009, Pages 949-955

  Tuncbilek, Nermin ^a   Kaplan, Mustafa ^a   Altaner, Semsi ^a   Atakan, Irfan H ^a   Süt, Necdet ^a   Inci, Osman ^a   Demir, Mustafa Kemal ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

Angiogenesis; Bladder cancer; Dynamic enhancement; MRI

Indexed keywords

GADOLINIUM CHELATE; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLOOD VESSEL DIAMETER; CANCER LOCALIZATION; CANCER RECURRENCE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; HEMODYNAMIC PARAMETERS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RECURRENT CANCER; TUMOR VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CONTRAST MEDIA; DISCRIMINANT ANALYSIS; FEMALE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOVASCULARIZATION, PATHOLOGIC; STATISTICS, NONPARAMETRIC; URINARY BLADDER NEOPLASMS;

EID: 63849281025     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.08.1332     Document Type: Article

References (40)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005; 55:10-30
2. Inoue K, Slaton JW, Karashima T, et al. The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy. Clin Cancer Res 2000; 6:4866-4873
3. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991; 324:1-8
4. Passe TJ, Bluemke DA, Siegelman SS. Tumor an-giogenesis: tutorial on implications for imaging. Radiology 1997; 203:593-600
5. Offersen BV, Knap MM, Marcussen N, Horsman MR, Hamilton-Dutoit S, Overgaard J. Intense inflammation in bladder carcinoma is associated with angiogenesis and indicates good prognosis. Br J Cancer 2002; 87:1422-1430
6. Folkman J. Angiogenesis: initiation and modulation. Symp Fundam Cancer Res 1983; 36:201-208
7. Xie Q, Zhang J, Wu PH, et al. Bladder transitional cell carcinoma: correlation of contrast enhancement on computed tomography with histo-logical grade and tumour angiogenesis. Clin Radiol 2005; 2:215-223
8. Weidner N. Intra-tumor microvessel density as a prognostic factor in cancer. Am J Pathol 1995; 147:9 -19
9. Schrier BP, Peters M, Barentsz JO, Witjes JA. Evaluation of chemotherapy with magnetic resonance imaging in patients with regionally meta-static or unresectable bladder cancer. Eur Urol 2006; 49:698-703
10. Buadu LD, Murakami J, Murayama S, et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histo-pathologic findings and tumor angiogenesis. Radiology 1996; 200:639-649
11. Dickinson AJ, Fox SB, Persad RA, Hollyer J, Sibley GN, Harris AL. Quantification of angiogene-sis as an independent predictor of prognosis in invasive bladder carcinomas. Br J Urol 1994; 74:762-766
12. Bochner BH, Cote RJ, Weidner N, et al. Angio-genesis in bladder cancer: relationship between microvessel density and tumor prognosis. J Natl Cancer Inst 1995; 87:1603-1612
13. Canoglu A, Gogus C, Beduk Y, Orhan D, Tulunay O, Baltaci S. Microvessel density as a prognostic marker in bladder carcinoma: correlation with tumor grade, stage and prognosis. Int Urol Nephrol 2004; 36:401-405
14. Tekes A, Kamel I, Imam K, et al. Dynamic MRI of bladder cancer: evaluation of staging accuracy. AJR 2005; 184:121-127
15. Scattoni V, Da Pozzo LF, Colombo R, et al. Dynamic gadolinium-enhanced magnetic resonance imaging in staging of superficial bladder cancer. J Urol 1996; 155:1594-1599
16. Tanimoto A, Yuasa Y, Imai Y, et al. Bladder tumor staging: comparison of conventional and gadolinium-enhanced dynamic MR imaging and CT. Radiology 1992; 185:741-747
17. Neuerburg JM, Bohndorf K, Sohn M, Teufl F, Guenther RW, Daus HJ. Urinary bladder neoplasms: evaluation with contrast-enhanced MR imaging. Radiology 1989; 172:739-743
18. Kim B, Semelka RC, Ascher SM, Chalpin DB, Carroll PR, Hricak H. Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2- weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging. Radiology 1994; 193:239-245
19. Matsubayashi R, Matsuo Y, Edakuni G, Satoh T Tokunaga O, Kudo S. Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors. Radiology 2000; 217:841-848
20. Peters-Engl C, Medl M, Mirau M, et al. Color-coded and spectral Doppler flow in breast carcinomas: relationship with the tumor microvascula-ture. Breast Cancer Res Treat 1998; 47:83-89
21. Gasparini G, Toi M, Gion M, et al. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. J Natl Cancer Inst 1997; 89:139-147
22. Tuncbilek N, Kaplan M, Altaner S, Okten OO, Atakan IH, Inci O. Analytical value of semi-quantitative parameters of dynamic MRG in determining grade and stage of bladder cancer. In: Proceedings of the 25th National Radiology Congress. Antalya, Turkey: National Radiology Congress, 2004:107
23. Ren J, Huan Y, Wang H, et al. Dynamic contrast-enhanced MRI of benign prostatic hyperplasia and prostatic carcinoma: correlation with angio- genesis. Clin Radiol 2008; 63:153-159
24. Barentsz JO, Jager GJ, Witjes JA, Ruijs JH. Primary staging of urinary bladder carcinoma: the role of MRI and a comparison with CT. Eur Ra-diol 1996; 6:129-133
25. Barentsz JO, Ruijs SH, van Erning LJ. Magnetic resonance imaging of urinary bladder cancer: an overview and new developments. Magn Reson Q 1993; 9:235-258
26. Bahri S, Chen JH, Yu HJ, Kuzucan A, Nalcioglu O, Su MY. Can dynamic contrast-enhanced MRI(DCE-MRI) predict tumor recurrence and lymph node status in patients with breast cancer? Ann Oncol 2008; 19:822-824
27. Frouge C, Guinebretiere JM, Contesso G, Di Paola R, Blery M. Correlation between contrast enhancement in dynamic magnetic resonancemaging of the breast and tumor angiogenesis. Invest Radiol 1994; 29:1043-1049
28. Folkman J. Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 1995; 333:1757-1763
29. George ML, Dzik-Jurasz AS, Padhani AR, et al. Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer. Br J Surg 2001; 88:1628-1636
30. Amendola MA, Glazer GM, Grossman HB, Ais-en AM, Francis IR. Staging of bladder carcinoma: MRI-CT-surgical correlation. AJR 1986; 146:1179-1183
31. Fisher MR, Hricak H, Tanagho EA. Urinary bladder MR imaging. Part II. Neoplasm. Radiology 1985; 157:471-477
32. Murphy WM, Grignon DJ, Perlman EJ. Tumors of the kidney, bladder, and related urinary structures. Washington, DC: American Registry of Pathology, 2004:394
33. Oosterlinck W, van der Meijden A, Sylvester R, et al. Guidelines on TaT1(non-muscle invasive) bladder cancer. In: European Association of Urology Guidelines. The Netherlands: EAU, 2006
34. Philp EA, Stephenson TJ, Reed MW. Prognostic significance of angiogenesis in transitional cell carcinoma of the human urinary bladder. Br J Urol 1996; 77:352-357
35. Chaudhary R, Bromley M, Clarke NW, et al. Prognostic relevance of micro-vessel density in cancer of the urinary bladder. Anticancer Res 1999; 19:3479-3484
36. Stavropoulos NE, Bouropoulos C, Ioachim IE, et al. Prognostic significance of angiogenesis in superficial bladder cancer. Int Urol Nephrol 2004; 36:163-167
37. Dinney CP, Babkowski RC, Antelo M, et al. Relationship among cystectomy, microvessel density and prognosis in stage T1 transitional cell carcinoma of the bladder. J Urol 1998; 160:1285-1290
38. Mussurakis S, Buckley DL, Horsman A. Dynamic MR imaging of invasive breast cancer: correlation with tumor grade and other histological factors. Br J Radiol 1997; 70:446-451
39. Narisada H, Aoki T, Sasaguri T, et al. Correlation between numeric gadolinium-enhanced dynamic MRI ratios and prognostic factors and histologic type of breast carcinoma. AJR 2006; 187:297-306
40. Szabo BK, Aspelin P, Kristoffersen Wiberg M, Tot T, Bone B. Invasive breast cancer: correlation of dynamic MR features with prognostic factors. Eur Radiol 2003; 13:2425-2435